P J Marks, D M Bruten, D C Speller. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Cross Infection/drug therapyCross Infection/microbiologyDrug CombinationsDrug Resistance, MicrobialEnglandEscherichia coli/drug effectsEscherichia coli Infections/drug therapyEscherichia coli Infections/microbiologyFemaleHumansKlebsiella/drug effectsKlebsiella Infections/drug therapyKlebsiella Infections/microbiologyMaleSulfamethoxazole/therapeutic useTrimethoprim/therapeutic use
Substances: See more » Drug CombinationsTrimethoprimSulfamethoxazole
Year: 1977 PMID: 71593 DOI: 10.1016/s0140-6736(77)90294-x
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321